Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To assess the feasibility and acceptability of genuine pharmacy follow up of people wishing to lose weight.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 60 mg Orlistat | Purchased by consumer |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Orlistat | Drug | 60 mg |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in Physical activity | baseline to 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Change in dietary behavior | baseline to 1 year | |
| Evaluation of care pathway (e.g., consultation with doctors, use of nutritional information) | baseline to 1 year | |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Consumers purchasing orlistat in a pharmacy setting
Not provided
| Name | Affiliation | Role |
|---|---|---|
| GSK Clinical Trials | GlaxoSmithKline | Study Director |
Not provided
Not provided
| ID | Term |
|---|---|
| D050177 | Overweight |
| ID | Term |
|---|---|
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077403 | Orlistat |
| ID | Term |
|---|---|
| D007783 | Lactones |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
| Satisfaction with management (i.e., results on weight and treatment comfort) |
| baseline to 1 year |
| D012816 |
| Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |